Emmaus Life Sciences, Inc.
EMMA
$0.07
$0.019.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 217.97% | -43.13% | -11.61% | -213.63% | 48.03% |
| Total Depreciation and Amortization | 250.00% | 200.00% | 200.00% | 200.00% | -33.33% |
| Total Amortization of Deferred Charges | -10.94% | 65.66% | 151.32% | 105.80% | 85.51% |
| Total Other Non-Cash Items | 236.25% | 77.78% | 191.13% | 141.60% | -133.16% |
| Change in Net Operating Assets | 48.93% | 7.73% | 21.58% | 736.81% | 53.80% |
| Cash from Operations | 158.22% | -223.30% | 544.02% | 176.35% | 0.31% |
| Capital Expenditure | -100.00% | -- | 100.00% | -100.00% | 66.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.26% | -- | -- | -- | -13.40% |
| Cash from Investing | -27.31% | -- | 100.00% | -100.00% | -13.33% |
| Total Debt Issued | -100.00% | -7.79% | 267.69% | 65.50% | 103.00% |
| Total Debt Repaid | 12.19% | -16.96% | -235.57% | -87.88% | -128.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -640.49% | -103.48% | -85.64% | -128.77% | 20.85% |
| Foreign Exchange rate Adjustments | -100.00% | -190.00% | -8.33% | -94.74% | 150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 487.50% | -1,783.93% | 1,268.66% | -119.26% | -139.57% |